Related Experiment Video
Updated: Jul 13, 2026

Promotion of Survival and Differentiation of Neural Stem Cells with Fibrin and Growth Factor Cocktails after Severe Spinal Cord Injury
Published on: July 27, 2014
NIR-Responsive Functionalized Nanoflower for Acute Spinal Cord Injury.
Wenjuan Wang1,2,3, Haosen Zhao4,2,3, Hongkai Yang4,2,3
1First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121000, P. R. China.
This study introduces a Prussian blue nanoflower (KPBF) that reduces reactive oxygen species (ROS) and repolarizes M1 macrophages. This novel therapy shows promise for treating spinal cord injury (SCI) by alleviating neuroinflammation.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Neuroscience
Background:
- Spinal cord injury (SCI) pathogenesis involves reactive oxygen species (ROS) and M1 macrophages.
- Therapies targeting ROS elimination and M1 macrophage repolarization are needed for SCI.
- Current treatments face challenges in crossing the blood-spinal cord barrier (BSCB).
Purpose of the Study:
- To develop a Prussian blue-based nanoflower (KPBF) with antioxidant and photothermal properties.
- To enhance KPBF's ability to penetrate the BSCB for targeted SCI treatment.
- To evaluate KPBF's efficacy in repolarizing M1 macrophages and alleviating neuroinflammation in SCI.
Main Methods:
- Development of a Prussian blue-based nanoflower (KPBF).
- Incorporation of CKLVFFAED peptide for enhanced BSCB penetration.
- Assessment of KPBF's antioxidant activity, ROS scavenging, and M1 macrophage repolarization.
- Evaluation of NIR photothermal effects on SCI lesions in mice.
- Analysis of neuroinflammation markers and SCI recovery in treated mice.
Main Results:
- KPBF demonstrated antioxidant enzyme-like biofunctions, reducing ROS.
- Near-infrared (NIR) irradiation with KPBF effectively heated SCI lesions.
- CKLVFFAED peptide modification enabled significant KPBF penetration across the BSCB.
- KPBF successfully repolarized M1 macrophages, reducing neuroinflammation in SCI mice.
- KPBF treatment promoted acute SCI recovery.
Conclusions:
- KPBF serves as a versatile nanotherapeutic system for acute SCI.
- The developed KPBF exhibits potent antioxidant and immunoregulation activities.
- KPBF's ability to cross the BSCB and target M1 macrophages offers a promising therapeutic strategy for SCI.
More Related Videos
11:57Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury
Published on: February 23, 2015
09:08A Neurosphere Assay to Evaluate Endogenous Neural Stem Cell Activation in a Mouse Model of Minimal Spinal Cord Injury
Published on: September 13, 2018